92 related articles for article (PubMed ID: 21855303)
1. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):627-34. PubMed ID: 21855303
[TBL] [Abstract][Full Text] [Related]
2. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
3. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569
[TBL] [Abstract][Full Text] [Related]
4. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells.
Kuo YC; Chen HH
J Drug Target; 2010 Jul; 18(6):447-56. PubMed ID: 20528098
[TBL] [Abstract][Full Text] [Related]
5. Modulation of efflux proteins by electromagnetic field for delivering azidothymidine and saquinavir into the brain.
Kuo YC; Lu CH
Colloids Surf B Biointerfaces; 2012 Mar; 91():291-5. PubMed ID: 22136805
[TBL] [Abstract][Full Text] [Related]
6. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Kuo YC; Kuo CY
Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
[TBL] [Abstract][Full Text] [Related]
7. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
Kuo YC; Ko HF
Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
[TBL] [Abstract][Full Text] [Related]
8. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
Kuo YC; Wang CC
Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
[TBL] [Abstract][Full Text] [Related]
9. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
10. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
Kuo YC; Lee CL
Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
[TBL] [Abstract][Full Text] [Related]
11. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
12. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
13. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
14. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Lin PI; Wang CC
Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
[TBL] [Abstract][Full Text] [Related]
15. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
16. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
[TBL] [Abstract][Full Text] [Related]
18. Ternary complexes of pDNA, polyethylenimine, and gamma-polyglutamic acid for gene delivery systems.
Kurosaki T; Kitahara T; Fumoto S; Nishida K; Nakamura J; Niidome T; Kodama Y; Nakagawa H; To H; Sasaki H
Biomaterials; 2009 May; 30(14):2846-53. PubMed ID: 19232715
[TBL] [Abstract][Full Text] [Related]
19. Surface functionalisation of PLGA nanoparticles for gene silencing.
Andersen MØ; Lichawska A; Arpanaei A; Rask Jensen SM; Kaur H; Oupicky D; Besenbacher F; Kingshott P; Kjems J; Howard KA
Biomaterials; 2010 Jul; 31(21):5671-7. PubMed ID: 20434215
[TBL] [Abstract][Full Text] [Related]
20. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
Gvili K; Benny O; Danino D; Machluf M
Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
